Welcome to Novartis Investor Relations for the United States. Novartis (NYSE: NVS), which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader in the research and development of products that protect and improve health and well-being. Its core businesses are in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.
Sales & Reports
Our reports package consists of the following downloadable information as well as a webcast on our quarterly and full-year results.
US Investor Center
Information for investors on buying ADSs through Direct Purchase, material information on ADS proxy voting and Syngenta tax basis information.
